Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gossamer Bio (GOSS) Current Assets (2022 - 2025)

Gossamer Bio (GOSS) has 4 years of Current Assets data on record, last reported at $204.0 million in Q3 2025.

  • For Q3 2025, Current Assets fell 40.75% year-over-year to $204.0 million; the TTM value through Sep 2025 reached $204.0 million, down 40.75%, while the annual FY2024 figure was $309.9 million, 1.1% up from the prior year.
  • Current Assets reached $204.0 million in Q3 2025 per GOSS's latest filing, down from $235.9 million in the prior quarter.
  • Across five years, Current Assets topped out at $370.9 million in Q2 2024 and bottomed at $173.4 million in Q2 2023.
  • Average Current Assets over 4 years is $274.3 million, with a median of $275.5 million recorded in 2025.
  • Peak YoY movement for Current Assets: soared 113.93% in 2024, then crashed 40.75% in 2025.
  • A 4-year view of Current Assets shows it stood at $261.9 million in 2022, then grew by 17.05% to $306.5 million in 2023, then increased by 1.1% to $309.9 million in 2024, then crashed by 34.17% to $204.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $204.0 million in Q3 2025, $235.9 million in Q2 2025, and $275.5 million in Q1 2025.